Important Safety Information for Healthcare Professionals

DO NOT use TRUEresult®, TRUE2go® or TRUEtest™ products for patients receiving the following treatments:

  • Peritoneal dialysis using solutions containing icodextrin (Extraneal®, Icodial®) that is metabolized to maltose,
  • Injections or infusions of solutions containing galactose or maltose, including some human immunoglobulin preparations (Octagam® 5%, WinRho® SDF Liquid, or HepaGam B™),
  • Xylose absorption testing,
  • Intravenous solutions containing maltose,
  • Any drugs that contain or metabolize to maltose, galactose, or xylose (Orencia®, ADEPT® or BEXXAR®).
Using TRUEresult®, TRUE2go® or TRUEtest™ products when receiving the above treatments may cause false high glucose results. False high results may lead to inappropriate therapy, which may result in coma or death. For more information:

Safe Practice Recommendations for Healthcare Professionals:

  • At patient admission/presentation and periodically throughout the patient's stay at the facility, assess the presence and use of therapies containing interfering drugs (see above).
  • Use only laboratory methods for monitoring blood glucose levels in patients receiving interfering drugs.
  • If there are pre-print order sets for patients receiving interfering drugs, include a prescription to test blood glucose using only laboratory methods.
  • Establish facility protocols to verify point-of-care (bedside) blood glucose results with laboratory results for patients who are unresponsive or unable to communicate.

Our TRUE portfolio of products is available at your favorite retail store or mail service provider.